See how Dr. De Raet and his team at Brussels Heart Centre used ECMO and utilized the Crescent™* jugular dual lumen catheter on 41-year-old Bertin.
Grand Rounds are interactive global webcasts delivered by industry-leading experts on a wide range of relevant topics. Listen to Drs. Bavaria and Klautz discuss Today's SAVR Patient: Case Based Discussions Valve Design and Impact on Clinical Outcomes.
Advancing ECLS therapy, this catheter is designed to optimize your patient's blood flow.
Care and caution should be taken to avoid damage to vessels and cardiac tissue during cannulation or other cardiac surgery procedures.
A design platform for long-term durability. Interior-mounted leaflets that leverage our proprietary AOA™ tissue treatment.
No clinical data is available which evaluates the long-term impact of AOA treatment in patients.
A complete portfolio of rigid, semi-rigid, and flexible annuloplasty products designed specifically for a more physiological mitral and tricuspid valve repair.See Our Options
™*Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Crescent™* jugular dual lumen catheter is manufactured by MC3, Inc. and exclusively distributed by Medtronic. Crescent jugular dual lumen catheters are not approved in every geography.